NEW YORK, July 27- Cellomics, a Pittsburgh-based maker of cell-imaging technology, said recently that it sold its ArrayScan HCS System to Vertex Pharmaceuticals of Cambridge, Mass.

The ArrayScan Sytem is an automated system designed to measure and analyze cell activity as a way of determining function. The system can also be used to determine whether a drug is toxic or efficacious, Cellomics said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.